Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Bank of New York Mellon Corp Makes New Investment in Metsera Inc ...
Buy Metsera Inc Stock – MTSR Stock Quote Today & Investment Insights ...
Metsera Inc (MTSR) Six Month Summary: The Bright Spot in a Quiet ...
Pfizer finally wins bidding war to acquire Metsera - Drug Discovery ...
Metsera Reports First Quarter 2025 Financial Results and Continued ...
Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters
Metsera reveals data supporting long-acting obesity shot | BioPharma Dive
Metsera Announces Positive Phase 1 Results for MET-097, an Ultra-Long ...
Metsera raises $215M to accelerate obesity drug plans | BioPharma Dive
Pfizer Bets Big on Obesity Market With $7.3 Billion Metsera Acquisition
Pfizer to buy Metsera for $4.9 billion in obesity drug bet
Pfizer Wins Bidding War, Acquires Metsera for Over $10 Billion
Pfizer Reshapes Portfolio With Seagen And Metsera As COVID Winds Shift
Metsera holders vote to approve $10B sale to Pfizer, deal closes (update)
Weight-loss drug developer Metsera targets up to $1.78 billion ...
After Metsera Battle, Pfizer Heads to China for Another Obesity Deal ...
Metsera falls after accepting up to $10 billion offer from Pfizer | Reuters
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Pfizer to buy Metsera after winning bidding war with Novo Nordisk
Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects ...
Population Heath Partners Managing Partner and former Metsera CEO Whit ...
Pfizer acquisition of Metsera boosts D&D Pharmatech partnership value ...
Markets exhale as Novo Nordisk withdraws from Metsera bidding war ...
Pfizer and Metsera agree on merger after bidding war between Pfizer and ...
Pfizer to acquire obesity-focused Metsera in $4.9B deal
Pfizer wins bidding war for Metsera with $10B offer
Pfizer to acquire Metsera and its next-generation obesity portfolio - NLS
Metsera comes out of stealth with $290 million for obesity drugs
Novo Nordisk stock rises as drugmaker drops out of bidding war for Metsera
Weight-loss drug developer Metsera raises $275 million in US IPO | Reuters
Delaware judge does not see current need for court in Metsera bidding ...
Metsera Stock Rockets After Pfizer's $7.3b — Should You Still Invest ...
After internal setbacks, Pfizer buys obesity player Metsera | pharmaphorum
Metsera Stock Rockets After Pfizer's $7.3b — Should…
Pfizer Buys Metsera for $10B After Bidding War With Nordisk
Metsera Inc. Stock Soars: What’s Behind the Surge?
Metsera Inc. Stock Surge: Opportunity or Risk?
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025
Metsera shares fall as Pfizer-Novo Nordisk bidding war ends - New York ...
Metsera Inc. (NASDAQ:MTSR) Archives • BioTech Health X
Pfizer Acquires Weight Loss Drug Developer Metsera for $4.9 Billion ...
Metsera Announces Positive Topline Phase 2a Clinical Data for its Ultra ...
Stock Surge: Metsera Inc. Fights for Future
Metsera Shares Surge: Metsera hits $2.7 bln valuation as shares surge ...
METSERA INVESTOR ALERT by the Former Attorney General of Louisiana ...
Metsera weight-loss startup wants to compete with Novo and Lilly - Fast ...
Amneal and Metsera to Collaborate on Next-Generation Medicines for ...
Novo Nordisk’s Bid for Metsera Draws Attention of FTC Staff
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war ...
Metsera bulks up cash pile for shot at obesity | The Pharmaletter
Metsera Shares Rise as Monthly Weight Loss Injection Shaves Over 8% ...
Metsera follows up phase 1 weight loss data with $215M series B
Novo Nordisk Proposes Acquisition of Metsera in Strategic Move
Pfizer Signs $4.9B Deal to Acquire Obesity Drugmaker Metsera
Metsera Reports phase 1 Trial Results of MET-097, an Ultra Long-Acting ...
Pfizer to Acquire Metsera for $4.9 Billion, Entering Obesity Treatment ...
Metsera Announces Promising Phase 2a Results for Ultra-Long Acting GLP ...
Metsera Achieves Impressive Results in Obesity Treatment Trials ...
Obesity-Focused Metsera Launches IPO Amid Much Anticipation - Xtalks
Metsera to Showcase Next-Generation Obesity Therapies at ADA 2025 with ...
Recent Price Trend in Metsera Inc. (MTSR) is Your Friend, Here's Why
Pfizer to Acquire Metsera in a $10bn Deal as Board Backs
Pfizer completes Metsera acquisition in deal worth up to $10 bn - Tuko ...
Metsera Becomes The Prize In Obesity's Biggest Bidding War (MTSR ...
Metsera Secures $215 Million Series B Financing | citybiz
Pfizer Loses Legal Bid to Block Novo’s Metsera Offer | BoF
Pfizer to Acquire Metsera in $10 Billion Weight-Loss Drug Deal ...
Pfizer's Strategic Metsera Acquisition: A Game-Changer in the $150B ...
Why Metsera stock's 20% surge signals a fierce Pfizer-Novo Nordisk ...
Pfizer, Metsera reach $10B merger agreement as Novo bows out | BioWorld
Metsera (MTSR) Presented at the 85th Scientific Sessions of the ...
Pfizer Clinches $10 Billion Metsera Acquisition After Competitive ...
Pfizer Completes Acquisition of Metsera - NORTH AMERICAN BUSINESS
Venture Partners: Weight-loss drug developer Metsera raises $290 ...
Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet
Amneal and Metsera Announce Strategic Collaboration to Develop and ...
Pfizer Acquires Metsera for $7.3 Billion to Enhance Obesity Drug Portfolio
Metsera's 2024 Financial Results: A Deep Dive into Pipeline Progress ...
CT's Pfizer acquires obesity drug start-up in 'strategic milestone'
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After ...
Pfizer doubles down on weight-loss treatments with up to $7.3 billion ...
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says ...
Pfizer sues Metsera, Novo in effort to enforce buyout deal
Pfizer Sues Metsera, Novo Nordisk Over Breach of Merger Deal
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid | RNZ News
Why Metsera's Share Price Is Plummeting This Week | The Motley Fool
Soleno, enGene, Pfizer, Metsera: Readout Newsletter
Pfizer is losing its fight with Novo Nordisk to get back in the obesity ...
Pfizer Inc. (NYSE:PFE) Q1 2026 Earnings Call Transcript - Insider Monkey
Metsera: $290 Million Secured To Develop Medicines For Obesity And ...
Metsera, Inc. chemical industry news - chemXplore
Metsera, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider ...
Metsera, Inc. Lock-Up Agreement Expiration: 30-JUL-2025
Metsera, Inc. shares fall 1.51% premarket due to lock-up agreement ...
Pfizer to acquire weight-loss drug maker, Metsera, in $7.3bn deal ...
MTSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ...
Pfizer Inc. to Acquire Metsera, Inc. and its Next-Generation Obesity ...
Metsera, Inc. | Johnson Fistel
From UGG To 'Since 1974': Shock Name Change For Iconic Australian Boot ...
Metsera, Inc.: A Disruptive Force in Obesity Therapeutics – Why the ...
Metsera's complex choice between Novo and Pfizer
Metsera: Long-Acting MET-097i And Product Differentiation Nets Pfizer ...
Metsera, Inc. (MTSR)’s MET-233i Shows 8% Weight Loss in Phase 1
Pfizer Sues Rivals Metsera, Novo Nordisk Over Alleged Interference in ...
Metsera, Inc. (MTSR) Stock Price, News, Quote & History - Yahoo Finance
Metsera: $215 Million (Series B) Raised To Develop Medicines For ...
Will Pfizer’s Buyout Boost Metsera?
Pfizer's $10 Billion Acquisition of Metsera: A Game Changer in Obesity ...
Metsera's Weight-Loss Drug MET-097i Shows Strong Clinical Results ...
Why this newly public biotech could become a force in obesity ...
